1952.HK Current Ratio

The Current Ratio of Everest Medicines Ltd (1952.HK) is 8.36.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

1952.HK Current Ratio - Historical Value

Date	Value
2024-12-31	8.36
2023-12-31	8.36
2022-12-31	3.92
2021-12-31	9.95
2020-12-31	24.06
2019-12-31	0.26
2018-12-31	1.31

1952.HK Current Ratio - Peers Comparison

Ticker	Name	Value
300439.SZ	MedicalSystem Biotechnology Co Ltd	2.73
9969.HK	InnoCare Pharma Ltd	19.49
2616.HK	CStone Pharmaceuticals	1.60
300009.SZ	Anhui Anke Biotechnology Group Co Ltd	3.41
002675.SZ	Yantai Dongcheng Biochemicals Co Ltd	1.46
2696.HK	Shanghai Henlius Biotech Inc	0.50
300832.SZ	Shenzhen New Industries Biomedical Engineering Co Ltd	5.56
688656.SS	HOB Biotech Group Corp Ltd	1.39
000403.SZ	Pacific Shuanglin Bio-pharmacy Co Ltd	3.74
002030.SZ	Daan Gene Co Ltd	2.92
300685.SZ	Amoy Diagnostics Co Ltd	9.18
688336.SS	Sunshine Guojian Pharmaceutical Shanghai Co Ltd	8.39
002022.SZ	Shanghai Kehua Bio-Engineering Co Ltd	3.46
002880.SZ	Shenzhen Weiguang Biological Products Co Ltd	3.61
300841.SZ	Chengdu Kanghua Biological Products Co Ltd	4.39
600201.SS	Jinyu Bio-Technology Co Ltd	3.02
688198.SS	Beijing Balance Medical Technology Co Ltd	5.17
688278.SS	Xiamen Amoytop Biotech Co Ltd	4.34
002038.SZ	Beijing SL Pharmaceutical Co Ltd	8.60
300639.SZ	Guangdong Hybribio Biotech Co Ltd	5.04
300294.SZ	China Resources Boya Bio pharmaceutical Group Co Ltd	6.74
688298.SS	Zhejiang Orient Gene Biotech Co Ltd	3.31
688136.SS	Kexing Biopharm Co Ltd	1.45
688488.SS	Jiangsu Aidea Pharmaceutical Co Ltd	1.38
300406.SZ	Beijing Strong Biotechnologies Inc	9.28
603387.SS	Getein Biotech Inc	2.20
600645.SS	Vcanbio Cell & Gene Engineering Corp Ltd	1.65
688166.SS	BrightGene Bio-Medical Technology Co Ltd	1.56